76 related articles for article (PubMed ID: 3306809)
1. Thermal enhancement of radiation response: a growth delay study on superficial human tumour metastases.
Tait DM; Carnochan P
Radiother Oncol; 1987 Jul; 9(3):231-40. PubMed ID: 3306809
[TBL] [Abstract][Full Text] [Related]
2. Thermal enhancement of radiation-induced leg contracture.
Stone HB
Int J Radiat Oncol Biol Phys; 1990 Mar; 18(3):595-602. PubMed ID: 2318693
[TBL] [Abstract][Full Text] [Related]
3. Significance of additive heat effect in the therapeutic gain factor in combined hyperthermia and radiotherapy: murine tumor response and foot reaction.
Sougawa M; Urano M
Int J Radiat Oncol Biol Phys; 1991 Nov; 21(6):1561-8. PubMed ID: 1938566
[TBL] [Abstract][Full Text] [Related]
4. Thermoradiotherapy with hydralazine: the effect of preirradiation of the tumor bed on blood flow and growth delay of Ehrlich carcinoma.
Kozin SV; Kozina LV
Radiat Res; 1999 Jan; 151(1):79-84. PubMed ID: 9973088
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous treatment of an experimental tumour with fractionated radiation and infrared-A-hyperthermia.
Zywietz F
Indian J Exp Biol; 1996 Sep; 34(9):833-7. PubMed ID: 9014513
[TBL] [Abstract][Full Text] [Related]
6. Tumour growth delay as a clinical endpoint for the measurement of radiation response.
Yarnold JR; Bamber JC; Gibbs J
Radiother Oncol; 1986 Mar; 5(3):207-14. PubMed ID: 3517972
[TBL] [Abstract][Full Text] [Related]
7. Mild temperature hyperthermia and radiation therapy: role of tumour vascular thermotolerance and relevant physiological factors.
Griffin RJ; Dings RP; Jamshidi-Parsian A; Song CW
Int J Hyperthermia; 2010; 26(3):256-63. PubMed ID: 20210610
[TBL] [Abstract][Full Text] [Related]
8. The response of human tumour metastases to radiation and misonidazole.
Dawen PJ; Peckham MJ; Steel GG
Br J Cancer Suppl; 1978 Jun; 3():290-6. PubMed ID: 277247
[TBL] [Abstract][Full Text] [Related]
9. Combined local hyperthermia and x-irradiation in the treatment of metastatic tumours.
Brenner HJ; Yerushalmi A
Br J Cancer; 1976 Jan; 33(1):91-5. PubMed ID: 1252331
[TBL] [Abstract][Full Text] [Related]
10. Interaction of SR-4233 with hyperthermia and radiation in the FSaIIC murine fibrosarcoma tumor system in vitro and in vivo.
Herman TS; Teicher BA; Coleman CN
Cancer Res; 1990 Aug; 50(16):5055-9. PubMed ID: 2379171
[TBL] [Abstract][Full Text] [Related]
11. Combined effect of hyperthermia at 42 degrees C and irradiation dose of 2 Gy on two rat yolk sac tumor cell lines with different radio-thermosensitivity in vitro.
Tamaki Y; Mitsuhashi N; Sakurai H; Islam MS; Takahashi T; Akimoto T; Ishikawa H; Saitoh J; Muramatsu H; Niibe H
Anticancer Res; 2002; 22(6A):3143-8. PubMed ID: 12530057
[TBL] [Abstract][Full Text] [Related]
12. Preferential radiosensitization of human prostatic carcinoma cells by mild hyperthermia.
Ryu S; Brown SL; Kim SH; Khil MS; Kim JH
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):133-8. PubMed ID: 12118542
[TBL] [Abstract][Full Text] [Related]
13. Relationship between thermal dose and outcome in thermoradiotherapy treatments for superficial recurrences of breast cancer: data from a phase III trial.
Sherar M; Liu FF; Pintilie M; Levin W; Hunt J; Hill R; Hand J; Vernon C; van Rhoon G; van der Zee J; Gonzalez DG; van Dijk J; Whaley J; Machin D
Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):371-80. PubMed ID: 9308941
[TBL] [Abstract][Full Text] [Related]
14. Modification of the response of a quiescent cell population within a murine solid tumour to boron neutron capture irradiation: studies with nicotinamide and hyperthermia.
Masunaga S; Ono K; Suzuki M; Takagaki M; Sakurai Y; Kobayashi T; Akuta K; Akaboshi M; Kinashi Y; Abe M
Br J Radiol; 1997 Apr; 70(832):391-8. PubMed ID: 9166076
[TBL] [Abstract][Full Text] [Related]
15. The measurement of the regression of carcinoma of the bladder using ultrasonography and CT scanning during and after radical radiotherapy.
Bessell EM; Price HM; McMillan PJ
Radiother Oncol; 1990 Oct; 19(2):145-57. PubMed ID: 2123987
[TBL] [Abstract][Full Text] [Related]
16. Clinical use of thermal enhancement and therapeutic gain for hyperthermia combined with radiation or drugs.
Gillette EL
Cancer Res; 1984 Oct; 44(10 Suppl):4836s-4841s. PubMed ID: 6467236
[TBL] [Abstract][Full Text] [Related]
17. The new vascular disrupting agent combretastatin-A1-disodium-phosphate (OXi4503) enhances tumour response to mild hyperthermia and thermoradiosensitization.
Hokland SL; Horsman MR
Int J Hyperthermia; 2007 Nov; 23(7):599-606. PubMed ID: 18038290
[TBL] [Abstract][Full Text] [Related]
18. Thermal enhancement of both tumour necrosis factor alpha-induced systemic toxicity and tumour cure in rats.
van der Zee J; van den Aardweg GJ; van Rhoon GC; van den Berg AP; de Wit R
Br J Cancer; 1995 Jun; 71(6):1158-62. PubMed ID: 7779705
[TBL] [Abstract][Full Text] [Related]
19. Thermal treatment parameters are most predictive of outcome in patients with single tumor nodules per treatment field in recurrent adenocarcinoma of the breast.
Kapp DS; Cox RS
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):887-99. PubMed ID: 7591899
[TBL] [Abstract][Full Text] [Related]
20. The current and potential role of hyperthermia in radiotherapy.
Overgaard J
Int J Radiat Oncol Biol Phys; 1989 Mar; 16(3):535-49. PubMed ID: 2646256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
